Abstract
MA05.10 Patient-Initiated a Phase II study (WJOG12819L) to Assess the Efficacy of Osimertinib in Patients with EGFR Mutated T790M-Negative NSCLC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have